-83%

est. 2Y upside i

HealthcareSeed

BBy powders breast milk that's immunologically active & lasts 6 months

Rank

#213

Sector

Health Technology & Digital Health

Est. Liquidity

~4Y

Data Quality

Data: Medium

This opportunity presents moderate upside for a job seeker willing to embrace the higher risk of a seed-stage health tech company, as BBy's innovative, proprietary technology directly addresses a significant and costly challenge in hospital neonatal intensive care units.

Last updated: February 16, 2026

Bull (25%)+450%

BBy achieves rapid hospital adoption, secures a strong Series A/B round, and proves its technology's scalability and cost-saving impact, leading to a high-multiple acquisition.

Base (40%)+150%

BBy continues to expand its hospital network, raises a successful Series A round at a healthy valuation, and solidifies its market position, but faces slower scaling or increased competition.

Bear (35%)-90%

BBy struggles with further funding, market penetration is slower than expected, or a larger incumbent develops a competing solution, leading to a significant loss of equity value.

Est. time to liquidity~3.5 years

Community

Valuation Sentiment

Our model estimates -83% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.